KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares Repurchased
Ratios

Sarepta Therapeutics (SRPT) Long-Term Debt Issuances (2017 - 2018)

Sarepta Therapeutics (SRPT) has 5 years of Long-Term Debt Issuances data on record, last reported at $18.2 million in Q4 2018.

  • For Q4 2018, Long-Term Debt Issuances fell 96.64% year-over-year to $18.2 million; the TTM value through Dec 2023 reached $18.2 million, down 70.97%, while the annual FY2022 figure was $1.1 billion, N/A changed from the prior year.
  • Long-Term Debt Issuances reached $18.2 million in Q4 2018 per SRPT's latest filing, down from $44.4 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $540.4 million in Q4 2017 and bottomed at -$133000.0 in Q3 2015.
  • Average Long-Term Debt Issuances over 3 years is $129.4 million, with a median of $60.7 million recorded in 2018.
  • The widest YoY moves for Long-Term Debt Issuances: up 96.64% in 2018, down 96.64% in 2018.
  • A 3-year view of Long-Term Debt Issuances shows it stood at -$133000.0 in 2015, then soared by 406400.75% to $540.4 million in 2017, then tumbled by 96.64% to $18.2 million in 2018.
  • Per Business Quant database, its latest 3 readings for Long-Term Debt Issuances were $18.2 million in Q4 2018, $44.4 million in Q3 2018, and $77.1 million in Q2 2018.